The cytoskeleton has a unique property such that changes of conformation result in polymerization into a filamentous form. ␣B-Crystallin, a small heat shock protein (sHsp), has chaperone activities for various substrates, including proteins constituting the cytoskeleton, such as actin; intermediate filament; and tubulin. However, it is not clear whether the ''␣-crystallin domain'' common to sHsps also has chaperone activity for the protein cytoskeleton. To investigate the possibility that the C-terminal ␣-crystallin domain of ␣B-crystallin has the aggregation-preventing ability for tubulin, we constructed an N-terminal domain deletion mutant of ␣B-crystallin. We characterized its structural properties and chaperone activities. Far-ultraviolet (UV) circular dichroism measurements showed that secondary structure in the ␣-crystallin domain of the deletion mutant is maintained. Ultracentrifuge analysis of molecular masses indicated that the deletion mutant formed smaller oligomers than did the full-length protein. Chaperone activity assays demonstrated that the N-terminal domain deletion mutant suppressed heat-induced aggregation of tubulin well. Comparison of chaperone activities for 2 other substrates (citrate synthase and alcohol dehydrogenase) showed that it was less effective in the suppression of their aggregation. These results show that ␣B-crystallin recognizes a variety of substrates and especially that ␣-crystallin domain binds free cytoskeletal proteins. We suggest that this feature would be advantageous in its functional role of holding or folding multiple proteins denatured simultaneously under stress conditions.
INTRODUCTION
␣B-crystallin, which is a member of the family of small heat shock proteins (sHsps), functions as a molecular chaperone and maintains protein homeostasis by preventing substrate aggregation. Some papers have reported the association of ␣B-crystallin with cytoskeletal elements. For example, ␣-crystallin modulates the assembly of intermediate filament vimentin and stabilizes actin filaments in a phosphorylation-dependent manner (Nicholl and Quinlan 1994; Wang and Spector 1996) . We reported that ␣B-crystallin associates with tubulin (Arai and Atomi 1997; Fujita et al 2004; Sakurai et al 2005) . Previously, we reported that heat-induced denatured tubulin dimer aggregation could be suppressed by ␣B-crystallin, showing that ␣B-crystallin may bind to denatured/denatured intermediate forms of tubulins, but not to native tubulin dimers (Arai and Atomi 1997) . In addition, ␣B-crystallin directly associates with the surface of microtubule-associated protein (MAP) microtubules (Fujita et al 2004) . Denatured tubulin is reported to inhibit the assembly of native tubulin (Maccioni 1983) . It is possible that ␣B-crystallin binds nonnative tubulin to prevent microtubule disassembly and inhibits formation of abnormal microtubules by avoiding disorder within the denatured tubulin dimer.
The structure of ␣B-crystallin consists of 3 domains: the N-terminal hydrophobic domain (1-67), the conserved C-terminal ''␣-crystallin domain '' (68-149) , and a third domain extending into an exposed flexible C-terminal extension (150-175) (Carver et al 1992; Kim et al 1998; Wistow 1985) . Several sites appear to be involved in the chaperone function of ␣B-crystallin, including the N-terminal domain and the C-terminal conserved ␣-crystallin domain. For cytoskeletal proteins, a missense mutation in ␣B-crystallin, R120G, has been shown to cosegregate with a familial desmin-related myopathy (Vicart et al 1998) . The R120G mutation of ␣B-crystallin induces the aggregation of glial fibrillary acidic protein filaments (Perng et al 1999) . The conserved ␤-sheet motif formed by residues 139-148 of ␣B-crystallin and sHsps are predicted to bind to actin filaments (Mounier and Arrigo 2002) . On the other hand, the conserved region F24 through F27 near the N terminus is important for its insulin chaperone activity (Plater et al 1996) . Given the diversity of substrates and the number of domains responsible for chaperone activity, the functional regions might be substrate specific. For example, the ␣-crystallin domain might carry out chaperone functions for cytoskeletal proteins. However, this hypothesis remains to be confirmed because it has not yet been shown that the ␣-crystallin domain conducts a chaperone function for the cytoskeleton protein tubulin.
In this report, we asked whether the C-terminal ␣-crystallin domain of ␣B-crystallin was responsible for inhibiting tubulin aggregation. We constructed a deletion mutant lacking the N-terminal domain of ␣B-crystallin. The mutant was examined for its chaperone activity for tubulin and for 2 other substrates, alcohol dehydrogenase (ADH) and citrate synthase (CS), frequently chosen for model substrate assays. Furthermore, to exclude possible effects of different buffer conditions, phosphate buffer containing NaCl was commonly used throughout the study. The results of our study demonstrated that the conserved ␣-crystallin domain is important to prevent tubulin aggregation. Furthermore, the experiments showed that different proteins use different sequences in ␣B-crystallin to maintain their solubility during heat-induced aggregation.
MATERIALS AND METHODS

Chemicals
CS (EC 4.1.3.7) from pig heart was purchased from Roche (Basel, Switzerland). Yeast ADH, piperazine-NЈ-[2-ethanesulfonic acids] (HEPES), piperazine-N,NЈ-bis[2-ethanesulfonic acid] (PIPES), and guanosine triphosphate (GTP) were from Sigma (St Louis, MO, USA). Bovine serum albumin (BSA) was purchased from Pierce (Rockford, IL, USA). All other reagents used were of the highest grade.
Cloning of the deletion mutant lacking the N-terminal domain of ␣B-crystallin
To prepare the expression vector encoding the ␣B-crystallin deletion mutant lacking the N-terminal domain, ␣B-⌬N67-expressing clones were amplified by polymerase chain reaction (PCR) with pUC118-␣B-crystallin (GenBank accession P23928) (Atomi et al 1991) as a template and custom primers (EcoRI and XbaI restriction sites underlined) synthesized by Espec oligo (Tsukuba, Japan). Primers used were for the ␣B-⌬N67 mutant: top, 5Ј-GCGAAT TCATGCGTATGGAGAAGGACAG-3Ј; bottom, 5Ј-TACT CGAGCTACTTCTTAGGGGCTGCAG-3Ј. The PCR product was digested with EcoRI and XbaI and cloned into pMAL-c2 (New England Biolabs, Ipswich, MA, USA), thereby producing pMAL-␣B-⌬N67 protein. The DNA constructions were confirmed by DNA sequence analysis.
Expression and purification of the deletion mutant lacking the N-terminal domain of ␣B-crystallin
The pMAL-␣B-⌬N67 expression plasmid was used to transform competent Escherichia coli TB1 (New England Biolabs). The procedures used for expression and purification of protein were described previously (Muchowski et al 1997) . Two liters of SB medium containing 50 g/ mL ampicillin was inoculated with 3 mL of an overnight culture of transformed E. coli cells, and cells were grown with shaking at 37ЊC. The cells were incubated until the culture reached an optical density of ϳ0.6 at absorbance (A) ϭ 600 nm, at which point protein expression was induced by addition of isopropyl-␤-D-thiogalactopyranoside to a final concentration of 0.3 mM (Takara, Shiga, Japan). Four hours after induction, cells were washed by centrifugation at 6000 ϫ g for 15 minutes at 4ЊC and resuspended in 50 mL of TEN buffer (10 mM Tris-HCl, pH 8.0, 1 mM ethylenediaminetetraacetic acid [EDTA] , and 100 mM NaCl). The cells were harvested by centrifugation at 6000 ϫ g for 15 minutes at 4ЊC and resuspended in 50 mL of column buffer (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 200 mM NaCl). Cells were stored overnight at Ϫ30ЊC. After thawing in cold water with shaking, DNaseI (Takara) was added to the cells, and the cells were incubated at 37ЊC for 5 minutes. The cells were disrupted by sonication on ice by three 15-second cycles at 80 watts on an Ultrasonic disrupter (TOMY, Tokyo, Japan). Insoluble cellular debris was removed by sedimentation at 9000 ϫ g for 30 minutes at 4ЊC. Soluble fusion protein present in the supernatant was purified by adsorption to a 20-mL amylose resin affinity column (New England Biolabs) at 4ЊC. After washing with 10 column volumes of column buffer, bound fusion protein was eluted with column buffer that contained 10 mM maltose. Fusion proteins were concentrated with Vivaspin (Sartorius AG, Goettingen, Germany). The concentration of the purified fusion protein was determined by a protein assay (Bio-Rad, Hercules, CA, USA) with BSA as a standard.
Purification of the protein lacking the N-terminal domain of ␣B-crystallin
Maltose binding protein (MBP) was cleaved from the purified fusion protein with the use of protease Factor Xa, the recognition sequence of which is encoded in the pMAL-c2-␣B-⌬N67 vector within the fourth and fifth codons 5Ј from the coding region for ␣B-crystallin. Deleted Column 2 lists the average molecular mass of an ␣B-crystallin subunit (full-length and ␣B-⌬N67) calculated from its primary sequence. The values in column 3 are calculated from the sedimentation equilibrium analysis, and the values of column 4 are calculated from the average molecular mass (see Materials and Methods). Column 5 is the sedimentation coefficient calculated from sedimentation velocity analysis.
␣B-crystallin was purified by anion exchange chromatography at 4ЊC. Cleaved fusion protein was dialyzed against ion exchange buffer (10 mM Tris-HCl, pH 8.5, 20 mM NaCl, and 1 mM EDTA). MBP and Factor Xa were separated from the ␣B-crystallin deletion mutant protein by absorption to a 1-mL column Resource Q anion exchange resin (GE Healthcare, Bucks, UK). In the presence of ion exchange buffer, deletion mutant protein had no affinity for the Resource Q anion exchange resin and hence could be separated from MBP and Factor Xa. Preparations of mutant deletion protein were dialyzed overnight against 50 mM sodium phosphate, pH 7.0, and 150 mM NaCl and then concentrated on Vivaspin.
Purification of ␣B-crystallin and tubulin
Human full-length ␣B-crystallin and bovine tubulin were purified as previously described and stored at liquid nitrogen or Ϫ80ЊC (Arai and Atomi 1997; Sun et al 1997) . Purified protein preparations were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting with the use of antibodies recognizing the carboxyl-terminal decapeptide (SH) KPAVTAAPKK of rat ␣B-crystallin and monoclonal anti-␣-tubulin antibody (Sigma) to confirm their purity and identity, performed as described previously (Arai and Atomi 1997) .
Circular dichroism measurements
Far-UV circular dichroism (CD) spectra were measured with a Jasco J-720 spectropolarimeter. A 1-mm path length cell was used. CD spectra presented here are the average of 8 scans, smoothed by polynomial curve fitting. The protein concentration was 0.3 mg/mL, and the sample was in 50 mM sodium phosphate (pH 7.0), 100 mM NaCl buffer. The circular dichroism data are expressed as molar ellipticity (degrees cm 2 /dmol).
Analytical ultracentrifugation
Sedimentation equilibrium was carried out to determine the weight-averaged molecular mass (M W ) distributions of the ␣B-⌬N67 and full-length ␣B-crystallin. Sedimentation equilibrium experiments were performed in a Beckman Optima XL-I analytical ultracentrifuge (Beckman Coulter, Fullerton, CA, USA). Protein solutions were dialyzed extensively against 50 mM sodium phosphate (pH 7.0) and 100 mM NaCl at 4ЊC. Aliquots (120 L) of ␣B-⌬N67 and full-length ␣B-crystallin were loaded into 2-channel, 12-mm centerpieces, and 140 L of dialysate was loaded into the corresponding reference channels. Centrifugation was conducted in a 60-Ti rotor at 3000 rpm, 4000 rpm, and 5000 rpm for full-length ␣B-crystallin and 13 000 rpm, 19 000 rpm, and 24 000 rpm for the ␣B-⌬N67 protein to produce a sedimentation equilibrium at 20ЊC. Radial absorbance scans were collected in continuous scan mode at 230 nm every 2 hours with 20 replicates and a step size of 0.001 cm. Sedimentation velocity was performed in a Beckman XL-I analytical ultracentrifuge. Sample volumes of 400 L were centrifuged at 50 000 rpm for both ␣B-⌬N67 and full-length ␣B-crystallin at 20ЊC. Radial scans of absorbance at 230 nm were recorded. Data were analyzed with the SEDFIT program (National Institutes of Health, Bethesda, MD, USA). The partial specific volumes (v) at 20ЊC, were calculated from the amino acid compositions, and the solvent density was 1.005 g/cm 3 by ''sednterp'' (http://www.jphilo.mailway.com/download.htm) (Laue et al 1992) . The average number of subunits per assembly for full-length ␣B-crystallin and the N-terminal domain deletion mutant (␣B-⌬N67) listed in Table 1 were calculated with the formula: number of subunits per oligomer ϭ (average molecular mass calculated from analytical centrifugation)/(molecular mass of a single full-length ␣B-crystallin or N-terminal domain-deleted mutant [␣B-⌬N67] subunit).
Assay for chaperone activity
Assays to measure chaperone activity of ␣B-crystallin were performed with the use of previously established methods with minor modifications (Arai and Atomi 1997; Kamradt et al 2001; Kelley and Abraham 2003) . Tubulin, CS, and ADH were used as chaperone target proteins. For ADH or CS aggregation, the assay was performed in sodium phosphate buffer containing NaCl (50 mM sodium phosphate, 150 mM NaCl, pH 7.0) or HEPES buffer (40 mM HEPES, pH 7.5), respectively. For tubulin aggregation, the assay was performed in PME buffer (80 mM PIPES, pH 6.8, 1 mM MgCl 2 , 1 mM ethylene glycol tetraacetic acid [EGTA], 1 mM GTP). Alternatively, sodium phosphate buffer containing NaCl was used. Thermally induced protein aggregation was monitored by measuring the turbidity of the solution on a spectrophotometer (Beckman DU-65), with the temperature regulated by a water bath. Molar ratio was represented as (moles of chaperone as a monomer):(moles of substrate as a monomer). All aggregation experiments were normalized to control experiments, in which aggregation with the substrate alone was defined as being 100% of the total substrate aggregation.
RESULTS
Construction of the deletion mutant lacking the N-terminal domain of ␣B-crystallin
To investigate whether the conserved C-terminal ␣-crystallin domain of ␣B-crystallin includes the functional region for tubulin, we constructed a deletion mutant lacking the N-terminal domain of ␣B-crystallin (␣B-⌬N67).
We chose the cleavage site on the basis of the conserved ␣-crystallin domain (68-149 amino acids; Fig 1A) (Wistow 1985; Carver et al 1992; Kim et al 1998) .
After proteolytic cleavage of the MBP-tagged fusion protein, ␣B-⌬N67 included an additional 4 N-terminal, vector-derived amino acids (isoleucine, serine, glutamic acid, and phenylalanine). The untagged form of the ␣B-crystallin C-terminal domain eluted with Ͼ98% purity in the flow-through from the Resource Q anion exchange column. The peak fractions containing ␣B-⌬N67 were pooled and stored at Ϫ80ЊC. To confirm the purification of these proteins, we conducted SDS-PAGE and Western blot analysis with an anti-␣B-crystallin C-terminal antibody (Fig 1B) . The stained gel showed the anticipated bands with expected gel mobilities of 22 kDa for fulllength ␣B-crystallin and 12 kDa for ␣B-⌬N67. Densitometry revealed Ͼ95% purity (data not shown).
Structural characterization of the deletion mutant lacking the N-terminal domain of ␣B-crystallin
Next, to characterize the structure of the deletion protein (␣B-⌬N67), far-UV CD spectroscopy was performed. The spectrum of ␣B-⌬N67 showed negative ellipticity with a minimum at 215 nm, which was typical for a ␤-sheet conformation (Fig 2) . The spectrum was in agreement with the predicted secondary structure for the ␣B-⌬N67 region of ␣B-crystallin and the ␣-crystallin domain of ␣B-crystallin (Siezen and Argos 1983; Feil et al 2001) . The secondary structure indicated by the far-UV CD spectrum of full-length ␣B-crystallin was consistent with a previous . Protein aggregation was determined by light scattering at 350 nm. These assays were performed in PME buffer (80 mM PIPES, pH 6.8, 1 mM MgCl 2 , 1 mM EGTA, 1 mM GTP). study (Muchowski et al 1997) . Thus, analysis of the secondary structure of ␣B-⌬N67 shows that the anti-parallel ␤-sheet that is the main structure in the ␣-crystallin domain is maintained. Thus, it appears that the N-terminal domain deletion mutant, ␣B-⌬N67, retained the functional domain.
Next, for the purpose of investigating the oligomeric structure of ␣B-⌬N67, the average molecular masses of ␣B-⌬N67 and full-length ␣B-crystallin were determined by sedimentation equilibrium to be 69 Ϯ 12 kDa and 451 Ϯ 86 kDa, respectively ( Table 1 ). The number of subunits per assembly and its standard deviation calculated from the average molecular mass of ␣B-⌬N67 and full-length ␣B-crystallin were determined to be 5 Ϯ 1 and 22 Ϯ 4, respectively (Table 1) . On the basis of the results of the sedimentation velocity, the s-values of ␣B-⌬N67 and fulllength ␣B-crystallin were found to be 2.62 S and 14.5 S, respectively. The peaks of both samples were broad, suggesting that the protein exists not as a single species but in a dynamic equilibrium between oligomeric states. These results suggested that the N-terminal domain deletion mutant of ␣B-crystallin cannot form large oligomers.
Tubulin chaperone activity of the deletion mutant lacking the N-terminal domain of ␣B-crystallin
To investigate the functionality of ␣B-⌬N67 for tubulin, we asked whether the mutant could prevent tubulin aggregation. Tubulin was incubated at 42ЊC for 120 minutes, either alone or in the presence of the full-length ␣B-crystallin. As observed in Figure 3A , at a 1:4 (full-length ␣B-crystallin:tubulin) molar ratio, the aggregation of tubulin was reduced from 100 to 40 arbitrary units (a.u.). At a 1:2 (full-length ␣B-crystallin:tubulin) molar ratio, the aggregation of tubulin decreased from 100 to 50 a.u. in this buffer condition. Higher concentrations of ␣B-crystallin enhanced turbidity when PME buffer was used in the assay (Fig 3A) .
Next, we determined whether the deletion of the N-terminal domain of ␣B-crystallin influenced the chaperone activity for heat-induced tubulin aggregation. At a 1:4 (␣B-⌬N67:tubulin) molar ratio, the aggregation of tubulin was reduced from 100 to 14 a.u. (Fig 3B) . Thus, ␣B-crystallin lacking the N-terminal domain was quite efficient in preventing heat-induced aggregation of tubulin.
Characterization of the chaperone activity of the N-terminal domain deletion mutant for CS and ADH
To compare the ability of the ␣-crystallin domain to function with different substrates, chaperone activity was also performed with ADH and CS instead of tubulin. Because ADH and CS are sensitive to heat, the aggregation time was reduced to 60 minutes. At a 1:4 (full-length ␣B-crystallin:ADH) molar ratio, ADH aggregation decreased from 100 to 5 a.u. at maximum aggregation (Fig 4A) . In the ADH assay, ␣B-⌬N67 was less effective for ADH than for tubulin in preventing heat-induced aggregation. Specifically, at a 1:4 (␣B-⌬N67:ADH) molar ratio, ADH aggregation increased from 100 to 110 a.u. (Fig 4B) . Higher molar ratios of ␣B-⌬N67 did not prevent aggregation of ADH. At a 3.3:1 (␣B-⌬N67:ADH) molar ratio, ADH ag- gregation increased from 100 to 122 a.u. However, at the 60-minute time point, ␣B-⌬N67 delayed the increase of ADH aggregation. Thus, ␣B-⌬N67 has little inhibitory effect on ADH compared with its effect on tubulin.
Incubation of CS in the presence of full-length ␣B-crystallin resulted in decreased CS aggregation to 10 a.u. (10:1 full-length ␣B-crystallin:CS; Fig 4C) . A 25-fold excess of full-length ␣B-crystallin was necessary to prevent CS aggregation compared with the inhibition of tubulin or ADH. ␣B-⌬N67 for CS was unable to prevent heatinduced aggregation (Fig 4D) . At a 10:1 (␣B-⌬N67:CS) molar ratio, CS aggregation increased from 100 to 115 a.u. Excessive amounts of ␣B-⌬N67 did not prevent aggregation of CS. At a 40:1 (␣B-⌬N67:CS) molar ratio, CS aggregation increased from 100 to 103 a.u. Thus, ␣B-⌬N67 cannot prevent heat-induced CS aggregation.
Together, these results indicated that full-length ␣B-crystallin inhibits aggregation of tubulin, ADH, and CS. In contrast, an equivalent molar ratio of ␣B-⌬N67 did not prevent CS and ADH aggregation with similar efficiency, yet efficiently inhibited heat-induced tubulin. Hence, the chaperone activity of the N-terminal domain deletion mutant ␣B-⌬N67 seems to depend on the nature of the substrate.
Buffer effect on chaperone activity
We performed the chaperone activity assay with the use of previously reported conditions (Horwitz 1992; Arai and Atomi 1997; Buchner et al 1998; Figs 3 and 4) . However, the results for any one substrate might be affected by the buffer employed. The buffer was limited to sodium phosphate buffer (50 mM sodium phosphate, pH 7.0, 150 mM NaCl), which was used in ADH aggregation to exclude the effects derived from different conditions. With that buffer, the raw light scattering of tubulin alone or CS alone was lower than that using PME buffer or HEPES buffer (data not shown). Figure 5 shows that ␣B-⌬N67 prevents tubulin aggregation but not CS aggregation in sodium phosphate buffer containing NaCl. At a 1:4 (fulllength ␣B-crystallin:tubulin) molar ratio, the aggregation of tubulin was reduced from 100 to 28 a.u. (Fig 5A) , whereas at the same 1:4 ratio of ␣B-⌬N67:tubulin, we observed reduced aggregation of tubulin (from 100 to 37 a.u.; Fig 5B) . Higher concentrations of ␣B-crystallin decreased aggregation of tubulin, as far as we investigated, when sodium phosphate buffer was used. Incubation of CS in the presence of full-length ␣B-crystallin resulted in decreased CS aggregation to 2 a.u. (20:1 full-length ␣B- crystallin:CS; Fig 5C) . At a 10:1 (␣B-⌬N67:CS) molar ratio, CS aggregation increased from 100 to 152 a.u. Because more ␣B-crystallin is needed to prevent CS aggregation compared with tubulin or ADH, ␣B-crystallin seems to function as a CS chaperone in an oligomeric form. In terms of oligomer molar ratios, both are the same molar ratio of 2:1 at 10:1 ␣B-⌬N67:CS and at 40:1 full-length ␣B-crystallin:CS from Table 1 . Hence, mutant ␣B-⌬N67 was less effective for CS than for an equal molar ratio of fulllength ␣B-crystallin. Thus, these results suggested that the N-terminal domain is not needed for tubulin chaperone activity but is required for ADH and CS, in spite of the difference of buffer conditions.
DISCUSSION
In this report, we asked whether the ␣-crystallin domain has chaperone activity for the cytoskeletal protein tubulin and compared the results with those obtained with CS and ADH. We constructed a deletion mutant of ␣B-crystallin with a truncated N-terminal domain, ␣B-⌬N67, and characterized its secondary structure and molecular mass. We showed that the hydrophobic N-terminal domain of ␣B-crystallin is not necessary for chaperone activity for denatured tubulin. Instead, the remainder of the ␣-crystallin domain is able to inhibit tubulin aggregation.
Analysis of the secondary structure of mutant ␣B-⌬N67 showed that the anti-parallel ␤-sheet conformation that is the main structure in the ␣-crystallin domain is maintained. Furthermore, it appears that the mutant retains functionality. Because the ␣-crystallin domain retained its structural integrity, deletion of the N-terminal domain of ␣B-crystallin did not dramatically affect its conformation.
The average molecular mass of the ␣-crystallin domain (␣B-⌬N67) and full-length ␣B-crystallin determined by sedimentation equilibrium suggests that the ␣-crystallin domain (␣B-⌬N67) cannot form large oligomers. It has been reported that wild-type ␣B-crystallin forms large oligomers and that the N-terminal region plays a role in the oligomerization. The results in this study are consistent with the previous report, as the truncation of the N-terminal domain of ␣B-crystallin inhibited the formation of oligomers (Feil et al 2001) . Thus, the N-terminal domain of ␣B-crystallin seems to be responsible for oligomer formation.
The ␣-crystallin domain (␣B-⌬N67) has been reported to associate with the cytoskeletal protein molecules actin and the intermediate filament vimentin (Vicart et al 1998; Perng et al 1999; Mounier and Arrigo 2002) . According to Vicart et al (1998) , the R120G mutation of ␣B-crystallin causes desmin aggregation in a desmin-related myopathy. Polar residues might contribute to the chaperone activity for cytoskeletal protein. In this report, we showed for the first time that the ␣-crystallin domain efficiently blocked heat-induced aggregation of tubulin. An important role of ␣B-crystallin might be to protect microtubules from stress by maintaining native tubulin amounts. Because the tubulin molecule is rich in polar amino acids, the polar regions of the ␣-crystallin domain might be involved in tubulin recognition. Given the requirement for the ␣-crystallin domain, the capacity of ␣B-crystallin to block tubulin aggregation could well require polar amino acids.
Usually, chaperone effects gradually increase depending on the concentration of chaperones; however, chaperone effect of full-length ␣B-crystallin is different. We observed that higher concentrations of full-length ␣B-crystallin increased turbidity in PIPES buffer in this study. This phenomenon was previously observed (Arai and Atomi 1997) . When sodium phosphate buffer is used instead of PME buffer in this study, prevention of aggregation is dependent on the concentration of full-length ␣B-crystallin (Fig 4) . Therefore, PME buffer might affect this phenomenon. Because PME buffer has usually been used in the polymerization of microtubules, some specific interactions might occur between the conformational change of tubulin to polymerize and full-length ␣B-crystallin. Interestingly in PIPES buffer, which might facilitate tubulin polymerization compared with PBS, mutant ␣B-⌬N67 (mainly ␣-crystallin domain) effectively inhibited tubulin aggregation in a concentration-dependent manner (Fig 2) . More precise experiments will be needed for characterization of these polymerization-directed conformational changes of the cytoskeletal proteins.
By comparing the activities of the ␣-crystallin domain on several chaperone substrates, the results clearly show that the region of ␣B-crystallin that inhibits aggregation of heat-denatured tubulin differed from that effective for CS and ADH. Recently, Ghosh et al (2006) reported that selectivity for unfolded target proteins varied with the specific amino acid composition in ␣B-crystallin. Hence, different proteins use different sequences in ␣B-crystallin to maintain their solubility during heat-induced aggregation.
Assay conditions used in the measurement of the chaperone activity, such as temperature, reaction buffers, and the denaturing procedures, were not uniform because the optimal conditions for denaturation differed between substrates. However, temperature is known to have different effects on secondary, tertiary, and oligomeric structures (Das and Surewicz 1995) and on chaperone activity (Raman et al 1995) . Therefore, we used the same buffers in the chaperone assay for all 3 substrates, to investigate whether the functional region in the deletion mutant showed different efficiencies with different substrates. We used sodium phosphate buffer, which mimics physiological conditions. By comparing the activities of the mutant on several chaperone substrates, the results clearly showed that the functional region of ␣B-crystallin for heat-denatured tubulin differed from that for CS and ADH and that different proteins use different sequences in ␣B-crystallin to maintain their solubility during heatinduced aggregation. Thus, these results suggest that the N-terminal domain is not needed for tubulin chaperone activity but is required for ADH and CS activities, in spite of the difference of buffer condition.
Moreover, our results in this study are complementary to these previous established roles of ␣B-crystallin. The intrinsic role of the cytoskeleton in the cell is to keep ''structure homeostasis,'' which is accomplished through ''protein homeostasis.'' Although sHsps are constitutively expressed in heart and slow muscles, the underlying reason has not been elucidated. Unlike ␣-crystallin in the lens, we suggest that the ␣B-crystallin domain of sHsps maintains a dynamic cytoskeleton within heart and skeletal muscles. On the basis of our results, we suggest that the very properties of the cytoskeleton (''treadmilling'' for actin/actin filaments, and dynamic instability of the tubulin/microtubule system) require sHsps (chaperones) to possess an ␣-crystallin domain. It was previously reported that sHsps might recognize an early change of protein conformation. We do not call the conformational changes through the polymerization ''denaturation''; however, the intrinsic property is similar. The cytoskeletal dynamics must be supported by sHsps.
We showed that the region of ␣B-crystallin that blocks tubulin aggregation is not located at the N-terminal domain but at the conserved C-terminal ␣-crystallin domain and is different from that for other substrates, such as CS and ADH. We suggest that multiple chaperone functional regions within the ␣B-crystallin molecule, each capable of recognizing a variety of specific substrates, would be an advantage in its functional role of holding or folding multiple proteins denatured simultaneously under stress conditions.
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